Form CORRESP - Correspondence:
SEC Accession No. 0001193125-22-246469
Filing Date
2022-09-16
Accepted
2022-09-16 17:00:54
Documents
3

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 41396
2 GRAPHIC g258714g0915100452320.jpg GRAPHIC 2534
3 GRAPHIC g258714g0915102002748.jpg GRAPHIC 2403
  Complete submission text file 0001193125-22-246469.txt   49417
Mailing Address 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA 98109
Business Address 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA 98109 206-456-2900
Silverback Therapeutics, Inc. (Filer) CIK: 0001671858 (see all company filings)

EIN.: 811489190 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations